TY - JOUR T1 - Application of ARIMA and Holt-Winters forecasting model to predict the spreading of COVID-19 for India and its states JF - medRxiv DO - 10.1101/2020.07.14.20153908 SP - 2020.07.14.20153908 AU - Mrutyunjaya Panda Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/31/2020.07.14.20153908.abstract N2 - The novel Corona-virus (COVID-2019) epidemic has posed a global threat to human life and society. The whole world is working relentlessly to find some solutions to fight against this deadly virus to reduce the number of deaths. Strategic planning with predictive modelling and short term forecasting for analyzing the situations based on the worldwide available data allow us to realize the future exponential behaviour of the COVID-19 disease. Time series forecasting plays a vital role in developing an efficient forecasting model for a future prediction about the spread of this contagious disease. In this paper, the ARIMA (Auto regressive integrated moving average) and Holt-Winters time series exponential smoothing are used to develop an efficient 20-days ahead short-term forecast model to predict the effect of COVID-19 epidemic. The modelling and forecasting are done with the publicly available dataset from Kaggle as a perspective to India and its five states such as Odisha, Delhi, Maharashtra, Andhra Pradesh and West Bengal. The model is assessed with correlogram, ADF test, AIC and RMSE to understand the accuracy of the proposed forecasting model.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMoHaFW daily data on COVID-19 Full COVID-19 data for India obtained from kaggle https://www.kaggle.com/imdevskp/covid-19-in-india ER -